Search results
Results from the WOW.Com Content Network
2009: Crown Bioscience US R&D site was founded. 2013: The company acquired PRECOS Ltd. (now Crown Bioscience UK Ltd.), and a bioluminescence imaging platform was established. 2014: Crown Bioscience Taiwan was founded. 2015: The western PDX models were expanded, and the company acquired Molecular Response (now Crown Bioscience San Diego, US).
This page was last edited on 3 February 2025, at 20:23 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
DSAT investigates incidents related to the laboratory use of select agents and toxins and refers cases to the FBI and HHS Office of Inspector General when necessary. [2] They also review experiments that are deemed "restricted experiments" because of their increased risk. [3] Samuel S. Edwin became the director of the division in 2016. [4]
The CDC has regulated the laboratories which may possess, use, or transfer select agents within the United States under the SAP since 2001. The SAP was established to satisfy requirements of the USA PATRIOT Act of 2001 and the Public Health Security and Bioterrorism Preparedness and Response Act of 2002, which were enacted in the wake of the September 11, 2001 attacks and the subsequent 2001 ...
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California.Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
Altos Labs was formally started on 19 January 2022. [2] The name Altos Labs is based on the city of Los Altos in California. [2] The idea for Altos Labs originated with cell biologist and entrepreneur Richard D. Klausner, who co-founded the company with Hans Bishop.
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. [1] It is headquartered in San Diego, California , and led by CEO Kevin Gorman. [ 3 ] Neurocrine develops treatments for neurological and endocrine-related diseases and disorders.
Aurora Biosciences was a biotechnology company founded in 1995 in San Diego to commercialize fluorescence assays based on Roger Y. Tsien's discoveries concerning green fluorescent protein and its uses in basic research - work for which Tsien eventually won the 2008 Nobel Prize in chemistry along with two other chemists.